These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 20458939

  • 21. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.
    Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P, Bierings M, Cetkovsky P, Kroes AC, van Tol MJ, Thouvenot D.
    Antivir Ther; 2005; 10(2):225-9. PubMed ID: 15865216
    [Abstract] [Full Text] [Related]

  • 22. Inhibitory effects of silver nanoparticles against adenovirus type 3 in vitro.
    Chen N, Zheng Y, Yin J, Li X, Zheng C.
    J Virol Methods; 2013 Nov; 193(2):470-7. PubMed ID: 23886562
    [Abstract] [Full Text] [Related]

  • 23. [In vitro Ingavirin efficacy against adenoviral infection pathogen].
    Loginova SIa, Borisevich SV, Maksimov VA, Bondarev VP, Nebol'sin VE.
    Antibiot Khimioter; 2009 Nov; 54(7-8):16-8. PubMed ID: 20201398
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of proteolytic processing of adenoviral proteins by epsilon-aminocaproic acid and ambenum in adenovirus-infected cells.
    Nosach L, Dyachenko N, Zhovnovataya V, Lozinskiy M, Lozitsky V.
    Acta Biochim Pol; 2002 Nov; 49(4):1005-12. PubMed ID: 12545207
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection.
    Arnold D, Di Biase AM, Marchetti M, Pietrantoni A, Valenti P, Seganti L, Superti F.
    Antiviral Res; 2002 Feb; 53(2):153-8. PubMed ID: 11750941
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of type 5 adenovirus infectivity by periodate oxidation.
    Ogier G, Michal Y, Thomas V, Quash G, Rodwell JD.
    Arch Virol; 1994 Feb; 135(1-2):43-60. PubMed ID: 8198449
    [Abstract] [Full Text] [Related]

  • 34. Studies of the effects of 5-iodo-2'-deoxyuridine on the formation of adenovirus type 2 virions and the synthesis of virus-induced polypeptides.
    Kan-Mitchell J, Prusoff WH.
    Biochem Pharmacol; 1979 Jun 15; 28(12):1819-29. PubMed ID: 454453
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cell Cycle-Dependent Kinase Cdk9 Is a Postexposure Drug Target against Human Adenoviruses.
    Prasad V, Suomalainen M, Hemmi S, Greber UF.
    ACS Infect Dis; 2017 Jun 09; 3(6):398-405. PubMed ID: 28434229
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.